LUNG Q3 2025 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$22M+5.5% YoY

Gross Profit

$16M74.7% margin

Operating Income

-$14M-66.9% margin

Net Income

-$14M-64.9% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-9.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$138M

Total Liabilities

$78M

Stockholders' Equity

$60M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$20M	+5.5%
Gross Profit	$16M	$15M	+6.8%
Operating Income	-$14M	-$14M	-1.9%
Net Income	-$14M	-$14M	+1.3%

Geographic Segments

UNITED STATES

$14M65%

EMEA

$7M31%

Asia Pacific

$842,0004%

Other International Geographical Areas

$68,0000%